TipRanks
Jeil Pharmaceutical Co. Ltd. (KR:271980)
:271980
South Korea Market
271980
Jeil Pharmaceutical Co. Ltd.
RESEARCH TOOLSreports

Jeil Pharmaceutical Co. Ltd. (271980) Ratios

― Followers

Jeil Pharmaceutical Co. Ltd. Ratios

KR:271980's free cash flow for Q2 2026 was ₩0.40. For the 2026 fiscal year, KR:271980's free cash flow was decreased by ₩ and operating cash flow was ₩-0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.33 1.29 1.18 1.00 1.09
Quick Ratio
 0.92 0.85 0.82 0.65 0.72
Cash Ratio
 0.24 0.20 0.18 0.10 0.12
Solvency Ratio
 0.08 0.14 -0.06 0.04 -0.01
Operating Cash Flow Ratio
 0.03 -0.02 0.01 -0.02 -0.06
Short-Term Operating Cash Flow Coverage
 0.07 -0.06 0.05 -0.08 -0.35
Net Current Asset Value
₩ 57.39B₩ 52.07B₩ 36.65B₩ -13.25B₩ -9.65B
Leverage Ratios
Debt-to-Assets Ratio
 0.21 0.18 0.14 0.15 0.11
Debt-to-Equity Ratio
 0.55 0.44 0.40 0.45 0.32
Debt-to-Capital Ratio
 0.35 0.31 0.29 0.31 0.24
Long-Term Debt-to-Capital Ratio
 0.03 0.00 0.00 0.00 0.02
Financial Leverage Ratio
 2.56 2.42 2.79 3.07 2.89
Debt Service Coverage Ratio
 0.25 0.31 -0.18 0.30 -0.06
Interest Coverage Ratio
 0.64 4.63 -3.74 1.45 -4.49
Debt to Market Cap
 0.76 0.41 0.43 0.25 0.15
Interest Debt Per Share
 7.95K 6.65K 5.54K 5.29K 3.66K
Net Debt to EBITDA
 2.17 1.36 -2.10 2.16 -15.64
Profitability Margins
Gross Profit Margin
39.07%36.79%25.19%25.37%21.71%
EBIT Margin
2.20%3.59%-3.11%1.09%-1.40%
EBITDA Margin
4.57%5.76%-1.51%2.44%-0.17%
Operating Profit Margin
0.55%3.59%-2.69%1.20%-1.87%
Pretax Profit Margin
3.44%6.17%-3.91%0.26%-1.83%
Net Profit Margin
1.71%4.13%-4.25%0.69%-1.81%
Continuous Operations Profit Margin
4.03%5.65%-4.36%0.72%-2.08%
Net Income Per EBT
49.86%66.91%108.79%261.20%98.82%
EBT Per EBIT
630.74%171.93%145.53%21.94%98.09%
Return on Assets (ROA)
1.77%4.58%-5.70%1.03%-2.87%
Return on Equity (ROE)
4.46%11.08%-15.93%3.16%-8.29%
Return on Capital Employed (ROCE)
1.07%7.58%-8.09%5.16%-7.17%
Return on Invested Capital (ROIC)
0.77%5.16%-6.17%3.70%-5.79%
Return on Tangible Assets
1.82%4.72%-5.85%1.04%-2.93%
Earnings Yield
6.30%10.50%-18.04%1.94%-4.28%
Efficiency Ratios
Receivables Turnover
 3.57 4.01 4.05 4.81 4.58
Payables Turnover
 4.66 4.03 3.92 3.76 3.73
Inventory Turnover
 3.17 3.43 5.05 4.94 5.70
Fixed Asset Turnover
 3.53 3.83 4.82 5.30 5.22
Asset Turnover
 1.03 1.11 1.34 1.49 1.58
Working Capital Turnover Ratio
 6.56 9.40 28.06 66.46 16.85
Cash Conversion Cycle
 138.99 106.81 69.23 52.58 45.86
Days of Sales Outstanding
 102.32 91.09 90.10 75.85 79.75
Days of Inventory Outstanding
 114.99 106.26 72.32 73.90 64.00
Days of Payables Outstanding
 78.32 90.54 93.19 97.18 97.89
Operating Cycle
 217.31 197.35 162.42 149.75 143.75
Cash Flow Ratios
Operating Cash Flow Per Share
 534.14 -386.92 220.49 -341.35 -1.04K
Free Cash Flow Per Share
 -396.99 -933.15 -233.31 -997.64 -2.20K
CapEx Per Share
 931.13 546.23 453.80 656.29 1.16K
Free Cash Flow to Operating Cash Flow
 -0.74 2.41 -1.06 2.92 2.12
Dividend Paid and CapEx Coverage Ratio
 0.57 -0.71 0.44 -0.48 -0.85
Capital Expenditure Coverage Ratio
 0.57 -0.71 0.49 -0.52 -0.89
Operating Cash Flow Coverage Ratio
 0.07 -0.06 0.04 -0.07 -0.30
Operating Cash Flow to Sales Ratio
 0.01 -0.01 <0.01 >-0.01 -0.02
Free Cash Flow Yield
-3.95%-6.16%-2.05%-5.63%-10.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 8.27 9.44 -5.54 51.66 -23.38
Price-to-Sales (P/S) Ratio
 0.27 0.39 0.24 0.36 0.42
Price-to-Book (P/B) Ratio
 0.72 1.06 0.88 1.63 1.94
Price-to-Free Cash Flow (P/FCF) Ratio
 -25.32 -16.24 -48.86 -17.76 -9.53
Price-to-Operating Cash Flow Ratio
 18.82 -39.16 51.70 -51.91 -20.21
Price-to-Earnings Growth (PEG) Ratio
 0.03 -0.05 <0.01 -0.37 -4.50
Enterprise Value Multiple
 8.12 8.19 -17.76 16.75 -268.82
Enterprise Value
 201.52B 267.32B 188.34B 296.73B 324.98B
EV to EBITDA
 8.12 8.19 -17.76 16.75 -268.82
EV to Sales
 0.37 0.47 0.27 0.41 0.45
EV to Free Cash Flow
 -34.52 -19.48 -55.40 -20.38 -10.12
EV to Operating Cash Flow
 25.66 -46.98 58.62 -59.58 -21.46
Tangible Book Value Per Share
 16.21K 16.02K 14.13K 10.47K 10.03K
Shareholders’ Equity Per Share
 14.00K 14.35K 12.91K 10.87K 10.83K
Tax and Other Ratios
Effective Tax Rate
 -0.17 0.08 -0.12 -1.71 -0.13
Revenue Per Share
 36.96K 38.51K 48.35K 49.78K 49.55K
Net Income Per Share
 633.59 1.59K -2.06K 343.00 -898.17
Tax Burden
 0.50 0.67 1.09 2.61 0.99
Interest Burden
 1.56 1.72 1.26 0.24 1.31
Research & Development to Revenue
 0.11 0.08 0.06 0.06 0.06
SG&A to Revenue
 0.21 0.16 0.12 0.11 0.10
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 0.53 -0.24 -0.11 -0.96 1.01
Currency in KRW